Visceral Manifold Study for the Repair of TAAA

NAActive, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

December 1, 2025

Study Completion Date

February 1, 2027

Conditions
Thoracoabdominal Aortic Aneurysms
Interventions
DEVICE

TAAA Debranching Stent Graft System

The TAAA Debranching Stent Graft System is made up of two main body components and makes use of several off-the-shelf FDA-approved stent graft components. The two custom main body grafts are the thoracic bifurcation and the visceral manifold. The thoracic bifurcation is deployed in the thoracic aorta and provides the proximal seal for the device. The two limbs of the thoracic bifurcation allows for continued aortic flow while deploying the visceral segment. The visceral manifold is deployed within the larger 20 mm limb of the thoracic bifurcation to set the stage for the visceral debranching. The branches of the visceral manifold extend to the visceral vessel with the use of covered bridging stents and provide distal seal of the manifold.

Trial Locations (2)

33606

Tampa General Hospital/ University of South Florida, Tampa

University of South Florida - South Tampa Campus, Tampa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

collaborator

Sanford Health

OTHER

lead

University of South Florida

OTHER

NCT03075748 - Visceral Manifold Study for the Repair of TAAA | Biotech Hunter | Biotech Hunter